Comprehensive managements of metastatic renal tumor with Mayo III inferior vena cava tumor thrombus: a case report

被引:1
作者
Miao, Chenkui [1 ]
Wang, Yuhao [1 ]
Hou, Chao [1 ]
Chen, Wen [2 ]
Xu, Aiming [1 ]
Wang, Zengjun [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Renal carcinoma; venous tumor thrombus; molecular targeted therapy; robotic surgery; case report; CELL CARCINOMA; TARGETED THERAPY; KIDNEY CANCER; SURGERY; EXPERIENCE;
D O I
10.21037/tau.2019.12.13
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Renal tumor with inferior vena cava (IVC) tumor thrombus still remains one of the most medical challenges in urological oncology. Despite numerous researches reporting the surgical experiences and survivals of this kind of patients, there is still lacking a standard recommended therapy right now. We reported a case of metastatic renal cell carcinoma with Mayo III IVC tumor thrombus who underwent robotic-assisted complete removal of the intracaval thrombus and radical left nephrectomy followed by renal arterial chemoembolization and pazopanib administration. It provides a new scheme and mode of diagnosis and treatment for this kind of patients. The patient was a 50-year-old man with left low-back pain for 20 days diagnosed with left renal tumor and Mayo III IVC tumor thrombus at the earliest. Initially, the patient underwent the renal arterial chemoembolization and targeted treatment to inhibit tumor's progression. After a two-year therapy period, the size of renal mass and lung nodules decreased than before, as well as the IVC tumor thrombus dropped to level II. Considering the efficacy of previous treatments, we performed robot-assisted IVC thrombectomy and radical left nephrectomy for this patient. The postoperative pathological examination confirmed the diagnosis of tumor thrombus as renal clear cell carcinoma. The patients recovered well after surgery and was followed-up for 36 months during the whole treatment course. This case with metastatic renal cell carcinoma (mRCC) and Mayo III IVC tumor thrombus received the interventional therapy, molecular targeted therapy and robot-assisted surgery successively, and acquired satisfying outcome. Patients with mRCC always suffer shorter overall survivals and aggressive progression compared with those localized tumors, therefore it is essential to formulate rational comprehensive treatment and carry out in time following-up.
引用
收藏
页码:812 / 818
页数:7
相关论文
共 22 条
  • [2] The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
    Blute, ML
    Leibovich, BC
    Lohse, CM
    Cheville, JC
    Zincke, H
    [J]. BJU INTERNATIONAL, 2004, 94 (01) : 33 - 41
  • [3] Robotic-assisted Radical Nephrectomy With Retrohepatic Vena Caval Tumor Thrombectomy (Level III) Combined With Extended Retroperitoneal Lymph Node Dissection
    Bratslavsky, Gennady
    Cheng, Jed-Sian
    [J]. UROLOGY, 2015, 86 (06) : 1235 - 1240
  • [4] Robot-assisted Level II-III Inferior Vena Cava Tumor Thrombectomy: Step-by-Step Technique and 1-Year Outcomes
    Chopra, Sameer
    Simone, Giuseppe
    Metcalfe, Charles
    Abreu, Andre Luis de Castro
    Nabhani, Jamal
    Ferriero, Mariaconsiglia
    Bove, Alfredo Maria
    Sotelo, Rene
    Aron, Monish
    Desai, Mihir M.
    Gallucci, Michele
    Gill, Inderbir S.
    [J]. EUROPEAN UROLOGY, 2017, 72 (02) : 267 - 274
  • [5] The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus
    Cost, Nicholas G.
    Delacroix, Scott E., Jr.
    Sleeper, Joshua P.
    Smith, Paul J.
    Youssef, Ramy F.
    Chapin, Brian F.
    Karam, Jose A.
    Culp, Stephen
    Abel, E. Jason
    Brugarolas, James
    Raj, Ganesh V.
    Sagalowsky, Arthur I.
    Wood, Christopher G.
    Margulis, Vitaly
    [J]. EUROPEAN UROLOGY, 2011, 59 (06) : 912 - 918
  • [6] Robotic Level III Inferior Vena Cava Tumor Thrombectomy: Initial Series
    Gill, Inderbir S.
    Metcalfe, Charles
    Abreu, Andre
    Duddalwar, Vinay
    Chopra, Sameer
    Cunningham, Mark
    Thangathurai, Duraiyah
    Ukimura, Osamu
    Satkunasivam, Raj
    Hung, Andrew
    Papalia, Rocco
    Aron, Monish
    Desai, Mihir
    Gallucci, Michele
    [J]. JOURNAL OF UROLOGY, 2015, 194 (04) : 929 - 936
  • [7] Renal cell carcinoma with tumor thrombus extension into the vena cava:: Prospective long-term followup
    Haferkamp, Axel
    Bastian, Patrick J.
    Jakobi, Hildegard
    Pritsch, Maria
    Pfitzenmaier, Jesco
    Albers, Peter
    Hallscheidt, Peter
    Mueller, Stefan C.
    Hohenfellner, Markus
    [J]. JOURNAL OF UROLOGY, 2007, 177 (05) : 1703 - 1708
  • [8] Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
    Karam, Jose A.
    Devine, Catherine E.
    Urbauer, Diana L.
    Lozano, Marisa
    Maity, Tapati
    Ahrar, Kamran
    Tamboli, Pheroze
    Tannir, Nizar M.
    Wood, Christopher G.
    [J]. EUROPEAN UROLOGY, 2014, 66 (05) : 874 - 880
  • [9] Tumor Thrombus Involving the Inferior Vena Cava in Renal Malignancy: Is There a Difference in Clinical Presentation and Outcome among Right and Left Side Tumors?
    Katkoori, Devendar
    Murugesan, Manoharan
    Ciancio, Gaetano
    Soloway, Mark S.
    [J]. INTERNATIONAL BRAZ J UROL, 2009, 35 (06): : 652 - 656
  • [10] A critical analysis of surgery for kidney cancer with vena cava invasion
    Kirkali, Ziya
    Van Poppel, Hein
    [J]. EUROPEAN UROLOGY, 2007, 52 (03) : 658 - 662